Insider trading · Q3 2026 · CIK 1745999

Beam Therapeutics Inc. (BEAM) insider trading.

Name: Beam Therapeutics Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Beam Therapeutics Inc. reported 10 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 6 sales worth $2.2M.

Transactions: 10
Purchases (P): 0
Sales (S): 6
Net shares, P minus S: -67,040
Insiders: 3
Last filed: 2026-09-25

Insiders

Insider	Relationship	Transactions	Sales
Evans John M.	Director, Officer · CEO	7	4
Simon Amy	Officer · Chief Medical Officer	2	2
Ciaramella Giuseppe	Officer · President	1	0

Transactions

10 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-24	Ciaramella Giuseppe	G (D)	123,407	$0	130,504	Form 4
2026-07-27	Simon Amy	S (D)	16,667	$25.74	85,696	Form 4
2026-06-30	Simon Amy	S (D)	373	$34.73	102,363	Form 4
2026-06-30	Evans John M.	M (A)	25,000	$1.03	1,072,205	Form 4
2026-06-30	Evans John M.	S (D)	23,100	$34.26	1,049,105	Form 4
2026-06-30	Evans John M.	S (D)	1,900	$34.84	1,047,205	Form 4
2026-06-29	Evans John M.	S (D)	11,579	$35.91	1,047,205	Form 4
2026-06-29	Evans John M.	S (D)	13,421	$35.13	1,058,784	Form 4
2026-06-29	Evans John M.	M (A)	6,337	$1.03	1,072,205	Form 4
2026-06-29	Evans John M.	M (A)	18,663	$0.67	1,065,868	Form 4

Transaction codes in this quarter

S: 6 M: 3 G: 1

Get BEAM insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1745999&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · BEAM company page · Beam Therapeutics Inc. on SEC.gov

Questions

Are insiders buying or selling Beam Therapeutics Inc. (BEAM)?

In Q3 2026, insiders at Beam Therapeutics Inc. reported 10 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 6 sales worth $2.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Beam Therapeutics Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/beam.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.